Top Chicago, IL Health Tech Companies With Best Stability & Growth (355)

Strong Market Position & Advantage: Independent rankings indicate Artera holds a leading position in patient communications, including a 2026 Best in KLAS win based on provider-sourced evaluations. Several summaries describe it as widely recognized as a category leader in this defined niche.

Strong Revenue Growth: Recent announcements cite surpassing $100M in contracted ARR by end of 2025 alongside scale metrics such as 1,000+ provider organizations and billions of annual communications. These signals collectively point to meaningful commercial momentum.

Innovation-Driven Growth: Momentum is frequently tied to AI capabilities (e.g., autonomous agents and co-pilots) adopted across hundreds of providers. Industry recognitions and coverage associate growth with expanding AI features and outcomes across patient access workflows.

Strong Revenue Growth: Reported revenue accelerated sharply year over year with continued guidance for expansion, and quarterly results showed momentum across both diagnostics and data businesses. Total remaining contract value and rising spend among existing customers support durability.

Strategic Partnerships: Multi‑year collaborations with leading biopharma and health systems, along with an international joint venture, signal deep ecosystem integration. These agreements include substantial data licensing and model‑development components that reinforce platform adoption.

Strong Market Position & Advantage: An FDA‑approved NGS companion diagnostic, broad provider reach across many U.S. academic medical centers, and a scaled multimodal oncology dataset underpin positioning as a leader in AI‑enabled precision oncology. Public‑company status and expanding trial‑matching capabilities further reinforce this standing.

Innovation-Driven Growth: Evidence indicates Prolaio has multiple FDA‑cleared algorithms, a large curated cardiovascular dataset, and integrated digital biomarker capabilities (e.g., physIQ), underpinning a differentiated RWD/AI platform. These regulated and data‑rich assets are being applied to clinical trials and connected care, signaling product and capability expansion.

Market Expansion: Materials cite operations in 26+ countries and explicit plans to extend access to Europe and Asia by 2026, alongside large, all‑remote study programs. Post‑acquisition integration within Kardigan is framed to extend the platform’s reach across more patients, providers, and biopharma partners.

Strong Hiring & Retention: Company updates highlight active recruiting and 2025 headcount additions (e.g., 32 new hires) plus ongoing openings across technical and operational roles. This hiring momentum, along with new operational suites and certifications (ISO/MDSAP), indicates organizational scaling capacity.

Investor Backing & Capital Strength: Advent International’s definitive agreement in August 2025 to acquire the company is presented as a strong signal of confidence in its leadership and growth prospects. The pending acquisition is framed around accelerating network expansion and product innovation.

Strong Market Position & Advantage: Independent and association coverage describes PatientPoint as operating the nation’s largest connected digital device network in tens of thousands of physician offices, bolstered by its 2021 combination with Outcome Health. Multiple sources characterize its leadership in terms of network size and advertiser reach.

Product Line Growth: Recent launches such as the Consumer Health Network and programmatic “Health Audiences” indicate expansion beyond traditional in‑office media into data‑driven activation. Partnerships and new offerings oriented to measurable outcomes suggest ongoing product momentum.

Innovation-Driven Growth: Recent launches such as "Ask ALIS" and the ongoing "ALIS 500" benchmarking program across 500 communities indicate a strong cadence of AI-led and data-driven innovation in assisted living. Public release notes and product pages highlight frequent domain-specific enhancements that advance capabilities.

Product Line Growth: The platform has expanded with new capabilities including AI-augmented features, enterprise reporting (ALIS HQ), family messaging, and an assisted-living-specific app store. Regular version releases (e.g., 9.5 and 9.6.x) signal sustained feature delivery and module depth.

Strategic Partnerships: Multiple integrations and certifications (e.g., FrameworkHL7, pharmacy and nurse-call/safety devices) and partnerships such as CarePredict embed ALIS in senior-living tech stacks. The site emphasizes 100+ to 130+ partner integrations, supporting broader interoperability and adoption.

Strong Market Position & Advantage: Independent KLAS rankings in 2024–2025 place StrataJazz Decision Support at the top of Business Decision Support, and multiple sources describe Strata as a category leader in U.S. provider finance. A broad installed base—thousands of hospitals across hundreds of systems—and recurring peer-reference activity reinforce this standing.

Market Expansion: The 2023 combination with Syntellis expanded the portfolio (e.g., Axiom and comparative analytics) and extended reach to higher education and financial services under the Strata brand. Recent materials citing more than 2,300 organizations and enlarged benchmarking datasets suggest a wider footprint than pre-combination.

Investor Backing & Capital Strength: Strata has been part of Roper Technologies since 2015, providing financial stability and a long-horizon operating model associated with vertical-market software. Public disclosures around the Syntellis transaction and ongoing integration indicate continued investment support.

Investor Backing & Capital Strength: Recent funding rounds and growth‑capital financing are cited as bolstering resources and runway. Industry coverage and company materials describe additional capital infusions that support expansion and product build‑out.

Strong Revenue Growth: Company reports indicate revenue and customer counts have increased sharply over consecutive years. Feedback suggests this momentum has continued alongside expanding platform adoption and hiring.

Strong Market Position & Advantage: Kalderos is frequently characterized as a pioneer and leader in manufacturer‑focused 340B duplicate‑discount prevention and claim‑level verification. Trade coverage and named manufacturer relationships underscore influence in this niche despite broader market segmentation.

Strong Market Position & Advantage: Analyst assessments from Everest Group, IDC MarketScape, and Forrester frequently place ZS in the Leader tier across life-sciences AI/analytics, digital services, HCP engagement, and R&D ITO. Feedback suggests this convergence of recent, scoped evaluations signals durable competitive standing in its core niches.

Market Expansion: ZS cites 13,000+ to 15,000+ professionals across 35–40+ offices and opened a new 50,000‑sq‑ft Hyderabad site, indicating expanded global delivery capacity. Capability-led acquisitions (e.g., Digital Additive; Torrent Consulting) further broaden geographic and service reach.

Innovation-Driven Growth: The firm launched a dedicated Platform & Products unit and is scaling ZAIDYN and Max.AI to embed AI and productized capabilities into client programs. Feedback suggests these moves position ZS for growth beyond services via AI-enabled, repeatable solutions.

Strong Market Position & Advantage: Humana is a top-tier player in Medicare Advantage with substantial local dominance across many counties and an integrated senior-care platform via CenterWell. Its scale in MA and senior-focused delivery underpins leadership in its core segment.

Strong Revenue Growth: Revenue has been rising, with year-over-year increases and higher 2025 guidance. Momentum is supported by CenterWell contributions and higher prescription volumes.

Future-Ready Strategy: Management is pruning low-margin geographies, repricing benefits, and concentrating on government programs and CenterWell to strengthen long-term earnings quality. Product and footprint adjustments for 2026, alongside early signs of star-rating stabilization, point to a rebuild path.

Strong Market Position & Advantage: Life Fitness is positioned as a market leader in U.S. commercial/B2B equipment and is described as a frequent anchor vendor in major gym rollouts, supported by a large global installed base and service network.

Innovation-Driven Growth: New platform launches (e.g., Symbio cardio), a continued product cadence into 2025, and the opening of an innovation center in 2026 indicate sustained investment in R&D and commercialization capability.

Investor Backing & Capital Strength: Private-equity ownership under KPS Capital Partners since 2019 is framed as providing backing for product/platform updates and portfolio management, supporting stability and investment capacity.